Showing results (51-60 of 245) with videos related to
Sort By:
Pageof 25
Leukemia Research|August 16, 2005
Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemiaJoli R Weiss, Julie A Baker, Maria R Baer, et al.Leukemia Research|December 21, 2007
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabineCecilia Arana-Yi, Annemarie W Block, Sheila N Sait, et al.Leukemia Research|December 7, 2005
Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patientsJeyanthi Ramanarayanan, Lauren M Dunford, Maria R Baer, et al.Biochemical Pharmacology|December 25, 2012
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsKarthika Natarajan, Jasjeet Bhullar, Suneet Shukla, et al.Cancer Genetics and Cytogenetics|April 15, 2008
Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosisBhuvaneswari Ramkumar, Manpreet K Chadha, Maurice Barcos, et al.Blood|November 20, 2012
The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignanciesDuan Wang, Linhao Li, Hui Yang, et al.Leukemia Research|March 26, 2013
Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelinesAmy J Davidoff, Sheila R Weiss, Maria R Baer, et al.Cancer Genetics and Cytogenetics|September 15, 2007
Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemiaSheila N J Sait, Melinda A Claydon, Jeffrey M Conroy, et al.Leukemia Research|May 9, 2006
Intakes of selected food groups and beverages and adult acute myeloid leukemiaYulin Li, Kirsten B Moysich, Maria R Baer, et al.The Journal of Clinical Investigation|February 3, 2015
Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapiesZhaoyang Li, Kenisha Younger, Ronald Gartenhaus, et al.Pageof 25